Analytical and preparative separation of phosphorothioated oligonucleotides: columns and ion-pair reagents

被引:45
作者
Enmark, Martin [1 ,2 ]
Bagge, Joakim [1 ]
Samuelsson, Jorgen [1 ]
Thunberg, Linda [3 ]
Ornskov, Eivor [4 ]
Leek, Hanna [3 ]
Lime, Fredrik [5 ]
Fornstedt, Torgny [1 ]
机构
[1] Karlstad Univ, Dept Engn & Chem Sci, S-65188 Karlstad, Sweden
[2] Uppsala Univ, Biomed Ctr, Dept Med Chem, Pharmacognosy, Box 574, S-75123 Uppsala, Sweden
[3] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Chem Dev, S-43183 Molndal, Sweden
[4] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Adv Drug Delivery, S-43183 Molndal, Sweden
[5] Nouryon, Separat Prod, S-44580 Bohus, Sweden
基金
瑞典研究理事会;
关键词
Ion-pair RPLC; Therapeutic oligonucleotides; Phosphorothioate; Diastereomers; Overloaded peaks; Preparative separations; LIQUID-CHROMATOGRAPHY; OMEPRAZOLE; RETENTION;
D O I
10.1007/s00216-019-02236-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotide drugs represent an emerging area in the pharmaceutical industry. Solid-phase synthesis generates many structurally closely related impurities, making efficient separation systems for purification and analysis a key challenge during pharmaceutical drug development. To increase the fundamental understanding of the important preparative separation step, mass-overloaded injections of a fully phosphorothioated 16mer, i.e., deoxythymidine oligonucleotide, were performed on a C18 and a phenyl column. The narrowest elution profiles were obtained using the phenyl column, and the 16mer could be collected with high purity and yield on both columns. The most likely contribution to the successful purification was the quantifiable displacement of the early-eluting shortmers on both columns. In addition, the phenyl column displayed better separation of later-eluting impurities, such as the 17mer impurity. The mass-overloaded injections resulted in classical Langmuirian elution profiles on all columns, provided the concentration of the ion-pairing reagent in the eluent was sufficiently high. Two additional column chemistries, C4 and C8, were also investigated in terms of their selectivity and elution profile characteristics for the separation of 520mers fully phosphorothioated deoxythymidine oligonucleotides. When using triethylamine as ion-pairing reagent to separate phosphorothioated oligonucleotides, we observed peak broadening caused by the partial separation of diastereomers, predominantly seen on the C4 and C18 columns. When using the ion-pair reagent tributylamine, to suppress diastereomer separation, the greatest selectivity was found using the phenyl column followed by C18. The present results will be useful when designing and optimizing efficient preparative separations of synthetic oligonucleotides.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 29 条
[1]   Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles [J].
Andersson, Shalini ;
Nelander, Hanna ;
Ohlen, Kristina .
CHIRALITY, 2007, 19 (09) :706-715
[2]   Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development [J].
Andersson, Shalini ;
Antonsson, Madeleine ;
Elebring, Marie ;
Jansson-Lofmark, Rasmus ;
Weidolf, Lars .
DRUG DISCOVERY TODAY, 2018, 23 (10) :1733-1745
[3]   The importance of ion-pairing in peptide purification by reversed-phase liquid chromatography [J].
Asberg, Dennis ;
Weinmann, Annika Langborg ;
Leek, Tomas ;
Lewis, Richard J. ;
Klarqvist, Magnus ;
Lesko, Marek ;
Kaczmarski, Krzysztof ;
Samuelsson, Jorgen ;
Fornstedt, Torgny .
JOURNAL OF CHROMATOGRAPHY A, 2017, 1496 :80-91
[4]   Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications [J].
Benizri, Sebastien ;
Gissot, Arnaud ;
Martin, Andrew ;
Vialet, Brune ;
Grinstaff, Mark W. ;
Barthelemy, Philippe .
BIOCONJUGATE CHEMISTRY, 2019, 30 (02) :366-383
[5]   RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform [J].
Bennett, C. Frank ;
Swayze, Eric E. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :259-293
[6]   Impurities in Oligonucleotide Drug Substances and Drug Products [J].
Capaldi, Daniel ;
Teasdale, Andy ;
Henry, Scott ;
Akhtar, Nadim ;
den Besten, Cathaline ;
Gao-Sheridan, Samantha ;
Kretschmer, Matthias ;
Sharpe, Neal ;
Andrews, Ben ;
Burm, Brigitte ;
Foy, Jeffrey .
NUCLEIC ACID THERAPEUTICS, 2017, 27 (06) :309-322
[7]  
Cox GB, 2005, PREPARATIVE ENANTIOSELECTIVE CHROMATOGRAPHY, P1, DOI 10.1002/9780470988428
[8]   An ab initio study on nucleic acid bases aromaticities [J].
Cysewski, P .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2005, 714 (01) :29-34
[9]  
Deshmukh R.R., 2000, SEP SCI TECHNOL, P511, DOI [10.1016/S0149-6395(00)80061-6, DOI 10.1016/S0149-6395(00)80061-6]
[10]   Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them? [J].
Eckstein, F .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (02) :117-121